Cannabis DeFloria Receives Investigational New Drug Application Clearance from FDA for Phase 2 Clinical Trial of AJA001, an Oral Cannabinoid Drug Being Developed for the Treatment of Autism Spectrum Disorder (ASD) February 26, 2025
Cannabis Software Effective Solutions Corp. / MedCana (OTC: SFWJ) Announces Milestone Achievement February 25, 2025
Cannabis Tempter’s Elevated Seltzers Powered WSWA Access LIVE 2025 with Country Music and Innovation February 23, 2025
Cannabis GVB Biopharma Launches State-of-the-Art Isolation Facility with Over 300,000-Kilo Annual Production Capacity February 20, 2025
Cannabis Distinctive Assets’ Legendary “Everyone Wins” Nominee Gift Bags Celebrate Hollywood’s Biggest Night While Giving Back to LA Fire Victims February 19, 2025
Cannabis Industrial Hemp Market to Grow by USD 18.31 Billion from 2025-2029, Driven by High Demand from the Textile Industry, Report on How AI is Driving Market Transformation – Technavio February 18, 2025
Cannabis FDA GRANTS FAST TRACK DESIGNATION TO PLEOPHARMA, INC’s INVESTIGATIONAL NEW DRUG, PP-01, FOR THE MITIGATION OF CANNABIS WITHDRAWAL SYMPTOMS IN PATIENTS WITH CANNABIS USE DISORDER: A POTENTIAL FIRST IN CLASS TREATMENT February 17, 2025